2nd International Conference on
Vaccines and Vaccination
August 20-22, 2012 Hilton Chicago/Northbrook, USA
Untitled Document
Vaccines-2012

    Previous Events
     
     
    Participants List from Academia
    Untitled Document
    University of Texas at Arlington, USA

    Stanford University School of Medicine, USA

    Mahidol University, Thailand

    Amirkabir University of Technology, Iran

    Hamdard University, India

    Yeshiva University, USA

    University of Macau, China

    Monash University, Australia

    University of Michigan, Ann Arbor

    Universidade Federal do Rio de Janeiro, Brazil

    University of Denver, Colorado

    University of Toronto, Canada

    Zagazig University, Egypt

    Banaras Hindu University, India

    Taipei Medical University, Taiwan

    University di Messina CNISM, Italy

    University of Tasmania, Australia

    Huazhong University of Science and Technology, China

    Sogang University, Korea

    University of Edinburgh, UK

    Martin-Luther-University Halle-Wittenberg, USA

    Universidade de Sao Paulo, Brazil

    Eve University, Turkey

    University of Delhi, India

    Isfahan University of Technology(IUT), Iran

    Taif University, Saudi Arabia

    University Medical Center, Netherlands

    University of Copenhagen, Denmark

    University Paris 13, France

     
    Participants List From Business
    Untitled Document
    Cadila Pharmaceuticals, India

    Chemical Works of Gedeon Richter, Hungary

    3S-Pharmacological Consultation & Research GmbH, Germany

    Royal Brisbane and Women's Hospital, Australia

    Psoriasis and Cutaneous Inflammation Research Laboratory, USA

    Alcon Laboratories Inc., USA

    National Institute for Materials Science (NIMS), Japan

    Grup de Recerca de Reumatologia (IRHVH), Spain

    Bayer Health Care, Richmond, USA

    Crown Bioscience Inc., China

    Hammersmith Hospital, London

    Van Drie Research LLC, USA

    Dr.Reddy's labs, India

    Merck Research Laboratories, USA

    National Institute of Pharmaceutical Education and Research (NIPER), India

    AstraZeneca R&D Boston, USA

    Abbott Laboratories, USA

    Hutchison MediPharma Limited, China

    Sage Bionetworks, USA

    Central Drug Research Institute, India

    Glenmark Pharmaceuticals, India

    National Institute for Interdisciplinary Science & Technology (NIIST) , India

    Novartis Campus, Austria


     
    Upcoming Conferences
    Day 1
    Scientific Program
      Day 2
    Scientific Program
      Day 3
    Scientific Program
    2nd International Conference on Vaccines & Vaccination, Vaccines-2012, will be organized around the theme "Prospects and Development of Prophylactic & Therapeutic Vaccines."

    Vaccines-2012 is comprised of 9 tracks and 56 sessions designed to offer comprehensive sessions that address current issues in Vaccines.

    Submit your abstract to any of the following tracks. All related abstracts are accepted.

    Register now for the conference by choosing an appropriate package suitable to you.
    Abstract Submission   Register
    Renowned Speakers
    speaker Gerardo Kaplan
    FDA, USA

    speaker John Dong
    GenPhar Inc, USA

    speaker Michael Vajdy
    EpitoGenesis Inc, USA

    speaker Anne De Groot
    EpiVax Inc, USA

    speaker Mark J Ahn
    Galena Biopharma Inc, USA

    speaker Conrad F Mir
    Genetic Immunity, USA

    speaker Maya Salnikova
    Merck Inc, USA

    speaker Daming Zhu
    National Institutes of Health, USA

    speaker Philip W. Askenase
    Yale University School of Medicine, USA

    speaker Marc Bonneville
    Inserm-Nantes University, France

    speaker Takashi Kei Kishimoto
    Selecta Biosciences, USA

    speaker Eli Young
    OpSaniTx, USA

    speaker Gavin Zealey
    Sanofi Pasteur, USA

    speaker Gregory M. Glenn
    Novavax, USA

    speaker Kei Amemiya
    U.S. Army Medical Research Institute of Infectious Diseases, USA

    speaker Nizar Souayah
    Director of EMG LAB & Peripheral Neuropathy Center, USA

    speaker De-chu Christopher Tang
    Vaxin Inc, USA

    speaker Cecil Czerkinsky
    The International Vaccine Institute, The Republic of Korea

    Track 1: Vaccines and the Basic Immune System
    Track 1-1 Innate and acquired immunity, attenuated, conjugated, toxoid, and subunit vaccines
    Track 1-2 Vectors and cell-based vaccine delivering technology
    Track 1-3 Development of immunity
    Track 1-4 Vaccine characterization, formulation, and delivery: New challenges and strategies
    Track 2: New Approaches for B and T Cells
    Track 2-1 Response of B and T Cells to the pathogens
    Track 2-2 New vaccine approaches
    Track 2-3 Immunotherapy and chemo immunotherapy
    Track 2-4 Nano and micro particles as adjuvants and delivery systems
    Track 2-5 Macrophage model systems
    Track 2-6 Targeted delivery approaches for vaccines
    Track 3: Cellular and Molecular-Based Vaccines
    Track 3-1 Peptide vaccines, DNA vaccines, cancer vaccines
    Track 3-2 Design and development of novel vaccines
    Track 3-3 Recombinant DNA vaccine technology
    Track 3-4 Polio vaccines, HIV vaccines
    Track 3-5 Development of vaccine for human papillomavirus
    Track 3-6 Carbohydrate / polysaccharide vaccine technology
    Track 4: Vaccines Against Infectious Diseases
    Track 4-1 Anti-parasite vaccines
    Track 4-2 Antiviral and antibacterial vaccines
    Track 4-3 Biodefence vaccines: The filovirus experience
    Track 4-4 Advance in novel pertussis vaccines
    Track 4-5 Novel adjuvants
    Track 4-6 Plant and animal based vaccines
    Track 4-7 Biomarkers in vaccines
    Track 4-8 Rotavirus vaccines
    Track 4-9 Pneumococcal vaccines
    Track 4-10 Emerging and re-emerging infectious disease vaccines
    Track 4-11 Food safety vaccines, glyco-conjugate vaccines
    Track 5: Manufacturing, Production, and Development of Vaccines
    Track 5-1 Innovative techniques for the multi-product vaccine
    Track 5-2 Robust and reproducible manufacturing techniques
    Track 5-3 QA/QC strategies in vaccine development and production
    Track 5-4 Technological improvements for downstream processing of vaccines
    Track 5-5 Generation of vaccines using high-throughput micro bioreactors
    Track 5-6 Mechanistic basic prophylactic and therapeutic vaccines
    Track 6: Regulatory and Ethical Issues of Vaccines and Public Acceptance
    Track 6-1 Risk assessment and management of vaccine usage
    Track 6-2 Case studies for HIV and tropical diseases
    Track 6-3 Personalized medicine development
    Track 6-4 Current issues in vaccine communication, safety, and health policies
    Track 6-5 Market trend and regulatory aspects of vaccine development and distribution
    Track 6-6 Epidemiological studies and scientific assessment of vaccine adverse events
    Track 7: Current Issues on Clinical Evaluation and Field Trials of Vaccines
    Track 7-1 Validation and optimization of treatment strategies for new targets
    Track 7-2 Vaccine trials: Clinical testing, defining efficacy endpoints, and confirmatory studies
    Track 7-3 Genetic predictors of immune response
    Track 7-4 Long term vaccine therapy for clonal exhaustion
    Track 7-5 Surveillance of vaccine preventable diseases
    Track 8: Modern Technologies in Vaccine Discovery and Development
    Track 8-1 Vaccine development strategies for neurodegenerative disorders
    Track 8-2 New developments in veterinary vaccines
    Track 8-3 Vaccine approaches to immunotherapy and clinical trials
    Track 8-4 Nanotechnology in vaccine delivery
    Track 8-5 Novel discoveries in allergen vaccines
    Track 8-6 Advances in the delivery methods for transcutaneous immunization
    Track 9: Age-specific Immune Response to Vaccination
    Track 9-1 Vaccination in pregnancy and newborns
    Track 9-2 Status and impact of childhood and adolescent immunizations
    Track 9-3 Vaccination in adults and older individuals: New perspectives
    Track 9-4 Travel immunizations and safety issues
    Track 9-5 Immunization in immunocompromised patients
    Track 9-6 Challenges in implementing immunization programs and strategies to improve them
     
    Conference Secretariat: Vaccines-2012, OMICS Group Conferences
    5716 Corsa Ave, Suite 110, Westlake, Los Angeles, CA 91362-7354, USA
    Phone: +1-650-268-9744, Fax: +1-650-618-1414
    Toll free: 1-800-216-6499(USA & Canada) l 1-800-651-097(Australia) l 0805-080048(Europe)
    Email: vaccines2012@omicsgroup.com
    Operated by: Editors - Journal of Vaccines & Vaccination and Journal of Clinical & Cellular Immunology
    The Organizers reserve the rights to make changes and adjustment to the information in this website
    Copyright 2008-2012 OMICS Group - All rights reserved
    Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version